Yannick Marc
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
QGC606: A Best-in-Class Orally Active Centrally Acting Aminopeptidase A Inhibitor Prodrug for Treating Heart Failure Following Myocardial Infarction.
Journal: The Canadian journal of cardiology
Published: June 24, 2021
Effects of firibastat in combination with enalapril and hydrochlorothiazide on blood pressure and vasopressin release in hypertensive DOCA-salt rats.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: February 03, 2021
Brain ACE2 activation following brain aminopeptidase A blockade by firibastat in salt-dependent hypertension.
Journal: Clinical science (London, England : 1979)
Published: November 12, 2020
Targeting Brain Aminopeptidase A: A New Strategy for the Treatment of Hypertension and Heart Failure.
Journal: The Canadian journal of cardiology
Published: January 31, 2020
Specific Inhibition of Brain Angiotensin III Formation as a New Strategy for Prevention of Heart Failure After Myocardial Infarction.
Journal: Journal of cardiovascular pharmacology
Published: December 12, 2018
Brain renin-angiotensin system blockade with orally active aminopeptidase A inhibitor prevents cardiac dysfunction after myocardial infarction in mice.
Journal: Journal of molecular and cellular cardiology
Published: August 09, 2018
Central antihypertensive effects of chronic treatment with RB150: an orally active aminopeptidase A inhibitor in deoxycorticosterone acetate-salt rats.
Journal: Journal of hypertension
Published: October 03, 2017
A new strategy for treating hypertension by blocking the activity of the brain renin-angiotensin system with aminopeptidase A inhibitors.
Journal: Clinical science (London, England : 1979)
Published: April 05, 2014
Inhibition of brain angiotensin III attenuates sympathetic hyperactivity and cardiac dysfunction in rats post-myocardial infarction.
Journal: Cardiovascular research
Published: December 22, 2012
Central antihypertensive effects of orally active aminopeptidase A inhibitors in spontaneously hypertensive rats.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: June 20, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026